1. Home
  2. FLYE vs IMRN Comparison

FLYE vs IMRN Comparison

Compare FLYE & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLYE
  • IMRN
  • Stock Information
  • Founded
  • FLYE 2018
  • IMRN 1994
  • Country
  • FLYE United States
  • IMRN Australia
  • Employees
  • FLYE N/A
  • IMRN N/A
  • Industry
  • FLYE Aerospace
  • IMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLYE Industrials
  • IMRN Health Care
  • Exchange
  • FLYE Nasdaq
  • IMRN Nasdaq
  • Market Cap
  • FLYE 15.5M
  • IMRN 15.0M
  • IPO Year
  • FLYE 2024
  • IMRN N/A
  • Fundamental
  • Price
  • FLYE $0.58
  • IMRN $2.69
  • Analyst Decision
  • FLYE
  • IMRN Strong Buy
  • Analyst Count
  • FLYE 0
  • IMRN 1
  • Target Price
  • FLYE N/A
  • IMRN $5.00
  • AVG Volume (30 Days)
  • FLYE 146.2K
  • IMRN 5.6K
  • Earning Date
  • FLYE 11-10-2024
  • IMRN 10-15-2024
  • Dividend Yield
  • FLYE N/A
  • IMRN N/A
  • EPS Growth
  • FLYE 1.84
  • IMRN N/A
  • EPS
  • FLYE 0.06
  • IMRN N/A
  • Revenue
  • FLYE $32,236,745.00
  • IMRN $3,271,194.00
  • Revenue This Year
  • FLYE N/A
  • IMRN N/A
  • Revenue Next Year
  • FLYE N/A
  • IMRN N/A
  • P/E Ratio
  • FLYE $9.73
  • IMRN N/A
  • Revenue Growth
  • FLYE 36.51
  • IMRN 171.67
  • 52 Week Low
  • FLYE $0.51
  • IMRN $1.48
  • 52 Week High
  • FLYE $7.62
  • IMRN $5.96
  • Technical
  • Relative Strength Index (RSI)
  • FLYE N/A
  • IMRN 51.76
  • Support Level
  • FLYE N/A
  • IMRN $2.66
  • Resistance Level
  • FLYE N/A
  • IMRN $2.87
  • Average True Range (ATR)
  • FLYE 0.00
  • IMRN 0.11
  • MACD
  • FLYE 0.00
  • IMRN 0.00
  • Stochastic Oscillator
  • FLYE 0.00
  • IMRN 54.85

About FLYE Fly-E Group Inc. Common Stock

Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Share on Social Networks: